Lantheus inks Mo-99 deal with MDS Nordion
Lantheus Medical Imaging has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope of technetium-99m.

Under terms of the new agreement, Lantheus will begin receiving an additional supply of Mo-99 on a weekly basis once the National Research Universal reactor at Chalk River, Ontario, is back online, which is currently anticipated to be at the end of July.

The North Billerica, Mass.-based Lantheus said the contract is in place until July 31, 2011.